1. Home
  2. CLDX vs PLSE Comparison

CLDX vs PLSE Comparison

Compare CLDX & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLDX
  • PLSE
  • Stock Information
  • Founded
  • CLDX N/A
  • PLSE 2014
  • Country
  • CLDX United States
  • PLSE United States
  • Employees
  • CLDX N/A
  • PLSE N/A
  • Industry
  • CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • PLSE Medical/Dental Instruments
  • Sector
  • CLDX Health Care
  • PLSE Health Care
  • Exchange
  • CLDX Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • CLDX 1.3B
  • PLSE 1.1B
  • IPO Year
  • CLDX 2008
  • PLSE 2016
  • Fundamental
  • Price
  • CLDX $20.10
  • PLSE $16.49
  • Analyst Decision
  • CLDX Buy
  • PLSE
  • Analyst Count
  • CLDX 9
  • PLSE 0
  • Target Price
  • CLDX $50.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • CLDX 664.5K
  • PLSE 163.2K
  • Earning Date
  • CLDX 05-08-2025
  • PLSE 05-08-2025
  • Dividend Yield
  • CLDX N/A
  • PLSE N/A
  • EPS Growth
  • CLDX N/A
  • PLSE N/A
  • EPS
  • CLDX N/A
  • PLSE N/A
  • Revenue
  • CLDX $7,559,000.00
  • PLSE N/A
  • Revenue This Year
  • CLDX N/A
  • PLSE N/A
  • Revenue Next Year
  • CLDX N/A
  • PLSE N/A
  • P/E Ratio
  • CLDX N/A
  • PLSE N/A
  • Revenue Growth
  • CLDX 24.49
  • PLSE N/A
  • 52 Week Low
  • CLDX $14.40
  • PLSE $6.66
  • 52 Week High
  • CLDX $47.00
  • PLSE $25.00
  • Technical
  • Relative Strength Index (RSI)
  • CLDX 53.76
  • PLSE 45.55
  • Support Level
  • CLDX $18.47
  • PLSE $15.72
  • Resistance Level
  • CLDX $20.42
  • PLSE $17.89
  • Average True Range (ATR)
  • CLDX 1.29
  • PLSE 0.83
  • MACD
  • CLDX -0.02
  • PLSE -0.11
  • Stochastic Oscillator
  • CLDX 60.32
  • PLSE 29.06

About CLDX Celldex Therapeutics Inc.

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.

Share on Social Networks: